Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer
- Citation:
- JAMA vol 307 (13) 1383-1393
- Year:
- 2012
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- 401 is parent abstract
- Pharmas:
- Grants:
- CA37377, CA-37404, N01 CA032102, U10 CA021115, U10 CA012027, U10 CA180835, CA12027, U10 CA031946, CA-14028, U10 CA037404, U24 CA114740, U10 CA014028, CA-114740, CA-35103, CA-25224, U10 CA035272, CA49957, CA-35113, CA-32102, U10 CA032102, U10 CA035113, CA-35272, U10 CA049957, CA21115, U10 CA025224, CA31946, U10 CA037377, U10 CA035103
- Corr. Author:
- Authors:
- Steven R. Alberts Daniel J. Sargent Suresh Nair Michelle R. Mahoney Margaret Mooney Stephen N. Thibodeau Thomas C. Smyrk Frank A. Sinicrope Emily Chan Sharlene Gill Morton S. Kahlenberg Anthony F. Shields James T. Quesenberry Thomas A. Webb Gist H. Farr Barbara A. Pockaj Axel Grothey Richard M. Goldberg
- Networks:
- Study
- NCCTG-N0147
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Article